|
|
Effect observation of Paroxetine combined with Olanzapine in the treatment of depression complicated with sleep disorder |
YU Fang-zhou HE Ru |
Department of Psychology,People′s Hospital of Liaoning Province,Liaoning Province,Shenyang 110016,China |
|
|
Abstract Objective To explore the clinical effect of Paroxetine combined with Olanzapine in the treatment of depression complicated with sleep disorder.Methods A total of 180 patients with depression complicated with sleep disorder admitted to People′s Hospital of Liaoning Province from June 2018 to October 2020 were selected as the study subjects.After being uniformly numbered,they were divided into the conventional group(n=90)and the experimental group(n=90)according to the method of single and double numbers.The conventional group was treated with Paroxetine Tablets alone,while the experimental group was treated with Paroxetine combined with Olanzapine.The clinical efficacy,sleep quality,depression and sleep were compared between the two groups.Results The total effective rate of the experimental group after treatment was 94.44%,which was lower than 83.33% of the conventional group,and the difference was statistically significant(P<0.05).There was no significant difference in the sleep quality and depression between the two groups before treatment(P>0.05).After treatment,the scores of Hamilton depression scale(HAMD)and Pittsburgh sleep quality index(PSQI)in the experimental group were lower than those in the conventional group,the total sleep time in the experimental group was longer than that in the conventional group,the sleep latency,awakening time in the experimental group were shorter than those in the conventional group,awakening times in the experimental group was less than that in the conventional group,and the differences were statistically significant(P<0.05).Conclusion The application of Paroxetine combined with Olanzapine in the treatment of depression complicated with sleep disorder can significantly improve the depression,sleep quality and sleep condition of patients,and also can improve the clinical total effective rate of patients,which is worthy of promotion and application.
|
|
|
|
|
[1] |
饶贵优.帕罗西汀联合奥氮平治疗抑郁症并发睡眠障碍效果观察[J].北方药学,2019,16(7):111-112.
|
[2] |
方明.帕罗西汀联合小剂量奥氮平治疗抑郁症伴失眠的临床疗效[J].临床合理用药杂志,2019,12(12):75-77.
|
[3] |
杨成超.观察帕罗西汀与奥氮平联合治疗抑郁症合并睡眠障碍患者的疗效及不良反应[J].中国药物经济学,2018,13(7):46-48.
|
[4] |
贺守彬.帕罗西汀+奥氮平治疗抑郁症伴失眠的效果[J].中国卫生标准管理,2020,11(1):82-84.
|
[5] |
关维波.奥氮平联合盐酸帕罗西丁治疗抑郁症的疗效观察[J].中国医药指南,2020,18(3):161-163.
|
[6] |
林贤颖,王勇,陈志民.奥氮平联合帕罗西汀治疗抑郁发作的临床疗效观察[J].实用中西医结合临床,2018,18(6):161-162.
|
[7] |
南晓荣,郭琴琴.帕罗西汀联合奥氮平治疗抑郁症并发睡眠障碍临床效果分析[J].科学养生,2019,22(12):93-94.
|
[8] |
曾惠英,宋丹杏,伍中坚.奥氮平联合盐酸帕罗西丁治疗抑郁症的疗效观察[J].现代诊断与治疗,2018,29(1):21-23.
|
[9] |
黄婴婷,戴标.奥氮平辅助治疗抑郁症患者的可行性[J].海峡药学,2019,31(10):163-164.
|
[10] |
汪允举.帕罗西汀联用奥氮平对难治性抑郁症患者的治疗效果分析[J].中国医药指南,2019,17(26):165-166.
|
[11] |
王道杰.帕罗西汀联合奥氮平治疗精神分裂症伴抑郁的疗效观察[J].中国现代药物应用,2018,12(23):84-85.
|
[12] |
庞继松.小剂量奥氮平辅助治疗抑郁障碍患者的效果及对血清神经递质和神经电生理指标的影响[J].海峡药学,2019,31(10):161-163.
|
[13] |
陆剑尧,龙丽云.帕罗西汀联合小剂量奥氮平对轻度抑郁伴失眠患者临床效果及睡眠指标分析[J].中国处方药,2019,17(12):66-67.
|
[14] |
龙清华,赵宾宾,徐波,等.三草安神方对抑郁症失眠大鼠海马凋亡相关蛋白表达的调节作用[J].中华中医药杂志,2019,34(4):1368-1371.
|
[15] |
何小明.老年抑郁症治疗中采用帕罗西汀与小剂量奥氮平的临床价值分析[J].药品评价,2019,16(24):59-60.
|
[16] |
高咏莉.奥氮平联合艾司西酞普兰对难治性抑郁症患者糖脂代谢及睡眠质量的影响[J].慢性病学杂志,2018,19(4):135-137.
|
[17] |
张广平,晏海飞,阮凌,等.帕罗西汀联合奥氮平治疗精神分裂症的疗效及对患者血清Hcy 水平和认知功能的影响[J].黑龙江医学,2018,42(12):1206-1207.
|
[18] |
朱永红,谢怀波,周巍.探讨奥氮平联合氟西汀治疗双相抑郁的疗效及安全性[J].海峡药学,2019,31(2):247-248.
|
|
|
|